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Summary
Objective: Beside matrix metalloproteinases, reactive oxygen species (ROS) are the main biochemical factors of cartilage degradation. To
prevent ROS toxicity, chondrocytes possess a well-coordinated enzymatic antioxidant system formed principally by superoxide dismutases
(SODs), catalase (CAT) and glutathione peroxidase (GPX). This work was designed to assess the effects of interleukin (IL)-1b and IL-6 on
the enzymatic activity and gene expression of SODs, CAT and GPX in bovine chondrocytes.
Methods: Bovine chondrocytes were cultured in monolayer for 4e96 h in the absence or in the presence of IL-1b (0.018e1.8 ng/ml) or IL-6
(10e100 ng/ml). To study signal transduction pathway, inhibitors of mitogen-activated protein kinases (MAPK) (PD98059, SB203580 and
SP600125) (5e20 mM) and nuclear factor (NF)-kB inhibitors [BAY11-7082 (1e10 mM) and MG132 (0.1e10 mM)] were used. SODs, CAT
and GPX enzymatic activities were evaluated in cellular extract by using colorimetric enzymatic assays. Mn SODs, Cu/Zn SOD, extracellular
SOD (EC SOD), CAT and GPX gene expressions were quantiﬁed by real-time and quantitative polymerase chain reaction (PCR).
Results: Mn SOD and GPX activities were dose and time-dependently increased by IL-1b. In parallel, IL-1b markedly enhanced Mn SOD and
GPX gene expressions, but decreased Cu/Zn SOD, EC SOD and CAT gene expressions. Induction of SOD enzymatic activity and Mn SOD
mRNA expression were inhibited by NF-kB inhibitors but not by MAPK inhibitors. IL-6 effects were similar but weaker than those of IL-1b.
Conclusions: In conclusion, IL-1b, and to a lesser extend IL-6, dysregulates enzymatic antioxidant defenses in chondrocyte. These changes
could lead to a transient accumulation of H2O2 in mitochondria, and consequently to mitochondria damage. These changes contribute to
explain the mitochondrial dysfunction observed in osteoarthritis chondrocytes.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis (OA) is one of the most common chronic dis-
eases and is a major cause of joint disability in elderly peo-
ple. Although OA is considered as a global disease
affecting all joint tissues, cartilage degradation is the end
point. Chondrocytes play a key role in cartilage degradation
by releasing metalloproteinases (mainly collagenases, stro-
melysins and aggrecanases) and reactive oxygen species
(ROS). Chondrocytes produce basically nitric oxide (

NO)
and superoxide anions (O2

) that generate derivative radi-
cals including hydroxyl radicals (

OH) and peroxynitrite
(ONOO)1e3. O2

production is increased by interleukin
(IL)-1b, tumor necrosis factor (TNF)-a4, cyclic stretch5 and1This work was supported by a grant of the Belgian National
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756oxidized low-density lipoprotein (ox-LDL)6.

NO production
is up-regulated by shear stress7, TNF-a, IL-1b8, IL-179, inter-
feron (IFN)g10, lipopolysaccharides, ﬁbronectin fragments11
and peroxynitrite-modiﬁed type II collagen12. When ROS pro-
duction exceeds the antioxidant capacities of the biological
medium, an oxidant stress occurs that leads to structural
and functional changes in chondrocytes and extracellular
matrix13,14. They include chondrocyte senescence and
death, matrix stiffness and brittleness15e17. All these
changes are key features of cartilage degradation in OA18.
Chondrocytes, as other mammalian cells, have a variety
of antioxidant defenses against the harmful effects of
ROS19. These include a well-coordinated enzymatic antiox-
idant system, essentially formed by superoxide dismutases
(SODs), catalase (CAT) and glutathione peroxidase (GPX).
SOD catalyzes the dismutation of O2

resulting in the pro-
duction of H2O2. Three distinct SODs are present in hu-
mans: cytosolic Cu/Zn SOD, mitochondrial Mn SOD and
extracellular SOD (EC SOD). SOD plays a critical but lim-
ited role in detoxifying ROS, as H2O2 can cause oxidative
stress if the levels of H2O2 detoxiﬁcation enzymes are
757Osteoarthritis and Cartilage Vol. 16, No. 7ineffective or depleted. CAT and GPX are the principal H2O2
detoxifying enzymes. Human chondrocytes constitutively ex-
press CAT, GPX and SOD20. Although, there are evidences
reporting the pathological role of ROS in cartilage degra-
dation, little is known about the antioxidant defense system
of chondrocytes. Using speciﬁc immunoassays, Mazzetti
et al.21 have compared Mn SOD and Cu/Zn SOD levels in hu-
man chondrocytes isolated from normal or OA cartilage. No
signiﬁcant difference was found between normal and OA
chondrocytes. In this model, IL-1b and TNF-a increased Mn
SOD production in OA chondrocytes, but not in normal cells.
TNF-a, but not IL-1b, increased Cu/Zn SOD production in OA
chondrocytes. Borsiczky et al.22 have reported an increase in
SOD activity in pig chondrocytes exposed to activated-
neutrophils or H2O2. In vitro, cyclic tensile stretch simulta-
neously increased both ROS and SOD activities and caused
depolymerization of hyaluronan indicating that ROS produc-
tion exceeded environmental antioxidant capacities5.
This work was designed to assess the effects of IL-1b
and IL-6, two cytokines involved in cartilage degradation,
on the enzymatic activity and gene expression of SOD,
GPX and CAT in bovine chondrocytes. This study also
aimed to identify the signaling pathway responsible for the
regulation by IL-1b of the antioxidant enzymes production.Materials and methodsPRIMARY CULTURE OF CHONDROCYTESNormal bovine articular cartilage was obtained from the metacarpale
phalangeal joint of 1e2-year-old steers shortly after death. Chondrocytes were
released from cartilage by sequential enzymatic digestions with 0.5 mg/ml
hyaluronidase type IV S (SigmaeAldrich, Bornem, Belgium) for 30 min,
1 mg/ml pronase E (Merck, Leuven, Belgium) for 1 h and 0.5 mg/ml clos-
tridial collagenase IA (SigmaeAldrich, Bornem, Belgium) for 18 h as previ-
ously described23. Cells were seeded in a 6-well plate at 0.5 106 cells/
well in 2 ml of Dulbecco’s Modiﬁed Eagle Medium (DMEM) supplemented
with 10% fetal calf serum, N-(2-hydroxyethyl)piperazine-N 0-(2-ethanesul-
fonic acid) (HEPES) 10 mM, penicillin (100 U/ml), streptomycin (0.1 mg/ml),
glutamine 2 mM and cultured for 5 days to achieve conﬂuence. For measur-
ing GPX activity, a large number of cells were needed. For this reason,
4 106 cells were seeded in 80 cm2 ﬂask and cultured in 15 ml of DMEM/se-
rum medium until conﬂuence. For all experiments, only primary cultures were
used to ensure the stability of chondrocyte phenotype.
Cells were made quiescent by 24 h incubation in a serum and phenol red-
free medium. Chondrocytes were cultured in the same medium for 4e96 h in
the absence or in the presence of recombinant porcine IL-1b (0.018e1.8 ng/
ml, RD System, Abingdon, UK) or recombinant human IL-6 (10e100 ng/ml, In-
vitrogen, Merelbeke, Belgium). Human IL-6 soluble receptor (50 ng/ml, RD
System, Abingdon, UK) was systematically added to each experiment testing
the effect of IL-6. IL-1b and IL-6 were tested at concentrations covering the
range of concentrations found in the synovial ﬂuid of arthritis patients. To
determine the signaling pathways involved in IL-1b effects, different mito-
gen-activated protein kinase (MAPK) and nuclear factor (NF)-kB pathways
inhibitors were also tested. The MAPK inhibitors were PD98059 (20-amino-
30-methoxyﬂavone, 5e10 mM,Calbiochem, Leuven, Belgium), an extracellular
signal-regulated kinase (ERK) inhibitor, SB203580 [4-(4-ﬂuorphenyl)-2-(4-
methylsulﬁnylphenyl)-5-(4-pyridyl)1H-imidazole, 5e20 mM, Promega, Leiden,
The Netherlands], a p38 kinase inhibitor and SP600125 (1,9-pyrazolanthrone,
5e10 mM, Calbiochem, Leuven, Belgium), a c-jun N-terminal kinase (JNK)
inhibitor. The NF-kB pathway inhibitors were MG132 (carbobenzoxy-L-
leucyl-L-leucinal, 0.1e10 mM, Calbiochem, Leuven, Belgium), an inhibitor of
proteasome and BAY11-7085 [3-(4-methylphenyl)sulfonyl)-2propenenitrite,
1e10 mM,Calbiochem, Leuven, Belgium], an inhibitor of phosphorylation of in-
hibitor of kB (IkB)-a. These inhibitors were dissolved in dimethylsulfoxide (ﬁnal
concentration 1/1000) and added to the cells’ culture 1 h before the addition of
cytokines. Controls were added with the same amount of dimethylsulfoxide. In
the same experiment, each culture condition was performed in triplicate and
each experiment was repeated three times using three different donors.EVALUATIONOFENZYMATIC ACTIVITYOF SODs, CAT ANDGPXSODs, CAT and GPX enzymatic activity was measured in cell extracts.
The cells were scrapped of in phosphate buffered saline (PBS), centrifuged
(300g, 10 min) and the supernatant discarded. The cell pellets were thenhomogenized in 1 ml of 50 mM TriseHCl, 5 mM ethylenediaminetetraacetic
acid (EDTA), pH 7.8 buffer by ultrasonic dissociation for 15 s at 4C. The so-
lution was then clariﬁed by centrifugation at 10,000g for 10 min at 4C and
the supernatants were used for SOD, CAT and GPX assays.
Total SOD-like activity was assessed with the SOD Assay Kit-WST
(Dojindo Molecular Technologies, Brussels, Belgium). SOD Assay Kit-WST
uses a highly water-soluble tetrazolium salt, WST-1 [2-(4-iodophenyl)-3-(4-
nitrophenyl)-5-(2,4-disulfo-phenyl)-2H-tetrazolium, monosodium salt], which
produces a water-soluble formazan dye upon reduction with superoxide an-
ion. Twenty microliters of cellular extract or puriﬁed SOD from erythrocytes
(Roche Diagnostics, Vilvoorde, Belgium) were mixed with 200 ml of TriseHCl
50 mM, pH 7.5 containing WST-1 50 mM, hypoxanthine 100 mM, xanthine ox-
idase 6 mU/ml and CAT 15 mg/ml. After an incubation of 20 min at 37C, the
absorbance was read at 450 nm. The within-run (intra-assay) imprecision,
assessed by measuring three samples 10 times in the same run, and the be-
tween-run (inter-assay) precision, determined from the same samples (n¼ 3)
assayed on 10 successive runs, were below 10%. Linearity was shown by
diluting the samples serially and comparing the observed values with those
expected. Typical recovery rate of 96.0e116.8% was noted in a range of di-
lution between 2- and 16- fold. Spiking recovery, determined by addition of
known quantities of Cu/Zn SOD (Roche Diagnostics, Vilvoorde, Belgium;
2.5 and 5 U/ml) into cellular extract was superior to 95%. The lower detection
limit of the assay was 0.2 U/ml of SOD. Mn SOD activity was differentiated
from Cu/Zn SOD by its resistance to 1 mM of KCN24. Cu/Zn SOD activity
was determined by subtracting Mn SOD activity from the total SOD activity.
CAT and GPX activities were determined by using, respectively, the Amplex
Red Catalase assay (Invitrogen, Merelbeke, Belgium) and the Cellular GPX
assay kit (Calbiochem, Leuven, Belgium). The activities of SOD, CAT and
GPX were calibrated using a standard curve prepared with puriﬁed bovine
erythrocytes SOD (Roche Diagnostics, Vilvoorde, Belgium), bovine liver
CAT (Sigma, Bornem, Belgium) and bovine erythrocytes GPX (Sigma, Bor-
nem, Belgium). Protein concentration of the cell extracts was determined by
a microassay (Bio-Rad, Nazareth, Belgium) using bovine serum albumin as
a standard. The activities were expressed as units per mg of protein. For
GPX and CAT, one unit of enzyme catalyzes the decomposition of 1 mM of
substrate per min. For SOD, one unit of enzyme inhibits reduction of cyto-
chrome C by 50% in a coupled system formed by xanthine and xanthine
oxidase.QUANTITATIVE REAL-TIME REVERSE TRANSCRIPTASE
POLYMERASE CHAIN REACTION (RT PCR)RNA from 3 106 cells was isolated by SV total RNA isolation system
(Promega, Leiden, The Netherlands). RNA (0.5 mg) was reverse transcribed
as previously described23. PCR was performed by using the Light Cycler-
FastStart DNA Master Sybr Green I (Roche Diagnostics, Vilvoorde, Belgium)
as previously described23. The PCR template source was either ﬁrst-strand
cDNA or puriﬁed DNA standard. Primer sequences used to amplify the de-
sired cDNA were as follows: bovine b globin forward and reverse primers:
50-TCCGTGGCCTTGGTCC-30 and 50-CGATCCCACTTAACTATCCG-30;
bovine Mn SOD forward and reverse primers: 50-GCAAGTAAACCGT-
CAGC-30 and 50-AACTACCACCTCCTAGC-30; bovine Cu/Zn SOD forward
and reverse primers: 50-CTGTCCAAAAAACACGGT-30 and 50-CAGGCTT-
GAGAGAATCG-30; bovine EC SOD forward and reverse primers: 50-
GGCCTTCTTCCACCTTGA-30 and 50-GGAGCGGTACTTCCAGAC-30; bo-
vine CAT forward and reverse primers: 50-GAACTGTCCCTACCGT-30 and
50-TCGTTGGCACTGTTGA-30 bovine GPX forward and reverse primers:
50-GGACTACACCCAGATGAA-30 and 50-GTGGCGTCGTCACTTG-30.
Gene expression was normalized by calculating the ratio between the num-
ber of cDNA copies of Mn SOD, Cu/Zn SOD, EC SOD, CAT or GPX and that
of b globin.STATISTICAL ANALYSISA one way-analysis of variance (ANOVA) was used to analyze statistical
signiﬁcance. Differences were considered statistically signiﬁcant at P< 0.05.
Correlations were assessed by Pearson correlation coefﬁcient.ResultsEFFECT OF IL-1b AND IL-6 ON SOD PRODUCTION BY
CHONDROCYTESAfter 24 h of incubation, IL-1b increased in a dose-depen-
dent manner the total SOD activity content in chondrocytes
(r¼ 0.76, y¼ 47.56þ 46.73x, P< 0.001) [Fig. 1(A)]. The IL-
1b-stimulating effect was also time-dependent. At 0.18 ng/
ml, IL-1b increased total SOD activity by 1.62 0.15,
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Fig. 1. Effect of IL-1b and IL-6 on SOD activity. A&C: Chondrocytes were incubated for 24 h with or without increased concentrations of IL-1b
or IL-6. B: Chondrocytes were incubated for 4e96 h without or with IL-1b (0.18 ng/ml) or IL-6 (100 ng/ml). D: SOD activity assay was per-
formed with KCN (1 mM) to discriminate Mn and Cu/Zn SOD activities. Each condition was tested in triplicate. Results are expressed as
mean S.E.M. of three independent experiments. ***P< 0.001 vs not stimulated with IL-1b; BBBP< 0.001 vs not stimulated with IL-6.
758 M. Mathy-Hartert et al.: Oxidative stress generation3.68 0.40 and 10.49 3.39-fold after 4, 24 and 96 h of
incubation, respectively (r¼ 0.92, y¼ 14.37þ 2.93x,
P< 0.001) [Fig. 1(B)]. It is noteworthy that the IL-1b-stimu-
lating effect was already signiﬁcant after 4 h of incubation.
After 24 and 96 h of incubation, but not at the shorter
time, IL-6 (100 ng/ml) signiﬁcantly stimulated SOD activity
(P< 0.001, 1.71 0.30-fold after 24 h and 2.16 0.38-fold
after 96 h) but to a lesser extent than IL-1b (P< 0.001)
[Fig. 1(B)]. After 24 h of incubation, IL-6 increased SOD ac-
tivity at the concentrations of 10, 30 and 100 ng/ml
(P < 0.001), but no signiﬁcant difference between these
concentrations was detected [Fig. 1(C)]. When they were
added simultaneously, IL-6 did not signiﬁcantly modify the
IL-1b-stimulated SOD activity (data not shown).
To discriminate Mn and Cu/Zn SOD activities, SOD activ-
ity assay was performed with KCN (1 mM), an inhibitor of
Cu/Zn SOD [Fig. 1(D)]. The increase in SOD activity by
IL-1b and IL-6 was due speciﬁcally to Mn SOD.
After 24 h of incubation, IL-1b increased Mn SOD gene
expression with a maximal effect at the concentration of
0.18 ng/ml, but dose-dependently inhibited Cu/Zn SOD
(r¼0.76, y¼ 5.584 1.58x, P< 0.01) and EC SOD
(r¼0.90, y¼ 1.37 0.60x, P< 0.001) [Fig. 2(AeC)]. IL-
6 also increased Mn SOD expression in dose-dependent
manner (r¼ 0.89, y¼ 19.64þ 0.10x, P< 0.001) (Fig. 3).EFFECT OF IL-1b AND IL-6 ON GPX PRODUCTION
BY CHONDROCYTESAfter 24 h of incubation, but not at the shorter time, IL-1b
signiﬁcantly increased by 1.30 0.12-fold GPX activity
(P< 0.01) [Fig. 4(A)]. This stimulating effect was signiﬁ-
cantly enhanced after 96 h of incubation with IL-1b
(P< 0.05) [Fig. 4(A)], suggesting a time-dependent effect
of IL-1b. IL-6 did not affect GPX activity and did not modify
the IL-1b-stimulating effect.After 24 h of incubation, GPX mRNA levels increased in
dose-dependent manner in response to IL-1b (r¼ 0.73,
y¼ 0.16þ 0.16x, P< 0.01) [Fig. 4(B)]. IL-6 also stimulated
GPX gene expression, but to a lesser extent than IL-1b.
The stimulating effect of IL-6 reached a maximum at the
lower concentration (10 ng/ml) [Fig. 4(B)].EFFECT OF IL-1b AND IL-6 ON CAT EXPRESSION
IN CHONDROCYTESAt the concentrations of 0.18 ng/ml and 1.8 ng/ml and
after 96 h of incubation, IL-1b signiﬁcantly inhibited CAT
activity (P< 0.05) [Fig. 5(A)]. At the concentration of
0.018 ng/ml, IL-1b had no signiﬁcant effect. After 4 or 24 h
of incubation, IL-1b (0.18 ng/ml) did not signiﬁcantly modify
CAT activity [Fig. 5(B)]. Whatever the concentration tested,
IL-6 did not signiﬁcantly modify CAT activity and did not
modulate the IL-1b-inhibitory effect (data not shown).
After 24 h of incubation, both IL-1b and IL-6 down-regulated
in dose-dependent manner CAT gene expression (IL-1b:
r¼0.87, y¼ 0.39 0.12x, P< 0.001; IL-6: r ¼ 0.92,
y¼ 1.28 0.0071x, P< 0.001) [Fig. 5(C)].EFFECTS OF MAPK AND NF-kB INHIBITORS ON SOD
PRODUCTIONTo investigate the possible role played by MAPK in the
stimulating effect of IL-1b on SOD production, chondrocytes
were exposed to SB203580 (10 and 20 mM), a p38 MAPK
inhibitor, SP600125 (10 and 20 mM) a JNK inhibitor, or
PD98059 (10 and 20 mM) an ERK inhibitor. Cell extracts
were assayed for SOD enzymatic activity and Mn SOD
gene expression. The inhibitors of MAPK failed to interfere
with the IL-b effect (data not shown).
To examine whether NF-kB mediated the IL-1b depen-
dent induction of SOD activity, we used two inhibitors of
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759Osteoarthritis and Cartilage Vol. 16, No. 7the NF-kB pathway: BAY11-7082, an inhibitor of IkB-a phos-
phorylation and MG132, a proteasome inhibitor. The IL-1b-
stimulated SOD activity was inhibited by BAY11-7082
at 5 and 10 mM (P< 0.001) and dose-dependently inhibited
by MG132 (r¼0.78, y¼ 83.21 5.93x, P< 0.001)
[Fig. 6(A)]. Similarly, the IL-1b-stimulating effects on Mn
SOD gene expression were signiﬁcantly decreased byBAY11-7082 at the concentrations of 5 and 10 mM
(P< 0.001), and dose-dependently inhibited by MG132
(r¼0.9, y¼ 286.8 58.5x, P< 0.05) [Fig. 6(B)]. It is note-
worthy that both the effect of IL-1b on SOD activity and Mn
SOD gene expression were fully blocked by BAY11-7082
and MG132 at the concentration of 10 mM.EFFECTS OF MAPK AND NF-kB INHIBITORS ON IL-1b
REGULATION OF CAT AND GPX GENE EXPRESSIONWhatever the concentration of inhibitor added, the inhib-
itory effect of IL-1b on CAT gene expression was not signif-
icantly modiﬁed by MAPK or NF-kB inhibitors. On the
contrary, SP600125 (10 mM) and PD98059 (10 mM), but
not SB203580 (20 mM), down-regulated IL-1b-stimulated
GPX RNA expression (Fig. 7), whereas none of the NF-
kB inhibitors had an effect on GPX expression.Discussion
The major ﬁnding of this paper is that IL-1b a key media-
tor of cartilage degradation in OA, dysregulate the enzy-
matic antioxidant defenses of chondrocytes. The
efﬁciency of enzymatic antioxidant defenses results of the
coordinated activity of SODs, which dismutates O2

into
H2O2, CAT and GPX activity which detoxiﬁes H2O2 into
O2 and H2O. For the ﬁrst time, we demonstrated that IL-
1b decoupled SODs and CAT/GPX activity in chondrocyte.
Indeed, IL-1b stimulated Mn SOD and GPX activity and
decreased CAT activity.
Mn SOD activity and gene expression were highly up-
regulated by IL-1b, which is consistent with earlier report
of the Mn SOD expression by IL-1b in OA chondrocytes21.
To the best of our knowledge, this is the ﬁrst study reporting
the effects of IL-1b on Cu/Zn SOD, EC SOD, CAT and GPX
gene expression and enzyme activity in chondrocyte. Inter-
estingly, Cu/Zn SOD and EC SOD gene expressions were
inhibited by IL-1b, while Mn SOD was increased, indicating
that IL-1b acts through different signaling pathways to reg-
ulate the expression of these genes. Further, this ﬁnding
suggests that the effect of IL-1b on the redox status is not
global but different in the mitochondria, the cytosol and
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760 M. Mathy-Hartert et al.: Oxidative stress generationthe extracellular environment. This supports the concept of
a targeted antioxidant therapy to treat oxidative stress re-
lated disease.
The rapid increase of Mn SOD may be interpreted as an
acute adaptive response to IL-1b-induced O2

overexpres-
sion, in order to protect mitochondria against O2

deleterious
effects. O2

itself is especially damaging to mitochondrial
aconitase, complex I and oxoglutarate deshydroge-
nase25,26. Damage to these enzymes by O2

undoubtedly
impairs the normal functioning of the citric acid cycle.
This, combined with the resulting inactivation of electron
transport processes and mitochondrial DNA deletion, then
results in energy depletion and progressive cell death. Nev-
ertheless, SOD is efﬁcient to detoxify ROS, only if SOD
activity is coupled with those of GPX and/or CAT, two en-
zymes eliminating H2O2. Interestingly, our study showed
that the early IL-1b-stimulating effect on Mn SOD activity
is associated with a delayed increase of GPX and decrease
of CAT activities. Indeed, the IL-1b-stimulating effects on
Mn SOD occur early, after only 4 h of incubation, whereas
the effects of IL-1b on GPX and CAT are delayed and
were signiﬁcant after 24 and 96 h, respectively. Therefore,
this uncoordinated antioxidant enzymatic activity could be
responsible for a rapid and transient mitochondrial accumu-
lation of H2O2. In contrary to SOD activity, CAT activity in-
creased with culture duration in our basal conditions,
probably due to the fact that CAT has a longer half-life
than SOD27. Therefore, we can hypothesize that thedelayed effect of IL-1b on CAT activity results of the higher
stability of this enzyme. Further, these results contribute to
explain the oxidative damages induced by IL-1b in chondro-
cytes. Some studies have previously reported that IL-1b in-
creased intracellular ROS ﬂux1,28,29,30 and that ROS are
responsible for the disruption of mitochondrial membrane
potential31.
This could explain the progressive mitochondria dysfunc-
tion and energy depletion observed in IL-1b treated mouse
chondrocyte-like ATDC5 cells, although this study suggests
that O2

and

NO were the main ROS involved in IL-1b ef-
fect31. The hypothesis that increased Mn SOD and H2O2
accumulation may have deleterious effects is supported
by two studies demonstrating that overexpression of Mn
0100
200
300
400
500
600
700
Cont IL-1ß 1 5 10 0.1 1 5
0
20
40
60
80
100
120
Cont IL-1ß 1 2 5 10 0.1 0.3 1 5 10
BAY11-7082(µM)
M
n 
SO
D
 n
or
m
al
iz
ed
ge
ne
 e
xp
re
ss
io
n
***
**
***
***
***
SO
D
 a
ct
iv
ity
 (U
/m
g)
***
***
***
***
***
***
MG132 (µM)
BAY11-7082(µM) MG132 (µM)
A
B
Fig. 6. Effects of NF-kB inhibitors on SOD activation by IL-1b. After 1 h of preincubation with BAY11-7082 (black bars) or MG132 (gray bars) at
indicated concentration, chondrocytes were treated with IL-1b (0.18 ng/ml) for the next 24 h. Cellular extracts were analyzed for SOD activity
(A) or Mn SOD gene expression (B). Each condition was tested in triplicate. Results are expressed as mean S.E.M. of three independent
experiments. ***P< 0.001: drug treated groups were signiﬁcantly different from the IL-1b treated groups.
0
0.2
0.4
0.6
0.8
1
1.2
G
PX
 n
or
m
al
iz
ed
 g
en
e e
xp
re
ss
io
n
co
n
t
SB
20
35
80
IL
-1
ß
PD
98
05
9
SP
60
01
25
B
A
Y
11
70
82
M
G
13
2
*** ***
Fig. 7. Effects of MAPK (black bars) and NF-kB inhibitors (gray
bars) on GPX gene expression. After 1 h of preincubation with
SB203580 (20 mM), SP600125 (10 mM), PD98059 (10 mM),
BAY11-7082 (10 mM) or MG132 (5 mM), chondrocytes were treated
with IL-1b (0.18 ng/ml) for the next 24 h. Cellular extracts were an-
alyzed for GPX gene expression. Experiments were performed
three times and data from a representative experiment are shown.
**P< 0.01 or ***P< 0.001: drug treated groups were signiﬁcantly
different from the IL-1b treated group.
761Osteoarthritis and Cartilage Vol. 16, No. 7SOD inhibited cell growth in NIH/3T3 ﬁbroblasts and rat gli-
oma cells and increased cell sensitivity to damage by radi-
ation and carcinogen32,33.
However, H2O2 has a low redox potential and thus have
a weak oxidizing and reducing power, suggesting that prob-
ably other H2O2-derived highly reactive oxygen and nitrogen
species are also involved in mitochondrial dysfunction. In
vitro and in the presence of complexed ferrous iron
(Fe2þ), H2O2 generates

OH (by the Fenton reaction) which
was recently reported to be responsible for mitochondrial
damages34. This suggests that cell culture conditions may
affect the cellular redox state and then inﬂuence the ﬁnal
impact of ROS on cellular function. Among these condi-
tions, oxygen tension and mechanical strains are probably
two key factors. In this study, chondrocytes were cultured
in atmospheric oxygen tension, while in vivo chondrocytes
live in 1e5% oxygen tension. Recently, it was reported
that oxygen tension inﬂuences the effect of IL-1 on peroxy-
nitrite formation by porcine chondrocytes. IL-1-induced per-
oxynitrite was decreased in 1% O2 as compared to 20%
30.
Therefore, we cannot exclude that IL-1b shows a different
effect on the antioxidant status of chondrocyte cultured in
low O2. Further, our observations were realized in the ab-
sence of mechanical stimuli, while in vivo chondrocytes
were submitted to static and cyclic loading. It was demon-
strated that physiological cyclic mechanical stimuli counter-
act the stimulating effects of IL-1b on the synthesis by
chondrocytes of catabolic and inﬂammatory mediators35.
Therefore, it is possible that in vivo, the antioxidant status
of normal chondrocytes exposed to physiologic mechanical
stimuli, was not modulated by IL-1b. In opposite, abnormal
762 M. Mathy-Hartert et al.: Oxidative stress generationloading may induced IL-1b secretion by chondrocytes and
act in synergy with this cytokine to promote cartilage degra-
dation36,37,38. This suggests that the dysregulation of the
antioxidant status by IL-1b is rather an aberrant feature
that occurs in chaotic circumstances than a physiological
process. As a consequence, we cannot deﬁnitively con-
clude about the metabolic impact of the IL-1b-induced dys-
regulation of the antioxidant enzymatic defense. Our study
suffers of some limitations. It is focused on the effects of
IL-1b on the enzymatic antioxidant defenses but fails to
do the link between these effects and the mitochondrial
functions. Future researches are needed to determine the
impact of Mn SOD overexpression on the mitochondrial
activity and energy production.
MAPK and NF-kBmediate many biological functions of IL-
1b. Our study showed that the stimulating effect of IL-1b on
Mn SOD activity and synthesis is abolished by proteasome
and IkB phosphorylation inhibitors, but not by MAPK inhibi-
tors. In contrast, IL-1b-stimulated GPX gene expression is
down-regulated by SP600125, a JNK MAPK inhibitor and
PD98059, an ERK MAPK inhibitor while SB203580, a p38
MAPK inhibitor and NF-kB inhibitors had no effect. This ﬁnd-
ing indicates that IL-1b regulates GPX and Mn SOD through
two different signaling pathways and might explain that IL-1b
effects on GPX and SOD occur at different time. Interest-
ingly, Mendes et al.39 demonstrated that the p38 MAPK cas-
cade is required for IL-1b induced inducible nitric oxide
synthase (iNOS) expression, while ERK MAPK and activat-
ing protein (AP-1) are not involved.
Since IL-1b and IL-6 have been known to share several
biological activities, and that IL-6 acts in synergy with IL-
1b to induce some catabolic and inﬂammatory processes
in OA joint, we investigate the effects of IL-6 on the enzy-
matic antioxidant defenses. Similarly to IL-1b, IL-6 stimu-
lated Mn SOD and GPX activity and gene expression, but
decreased CAT gene expression. IL-6 is known to induce
Mn SOD in several cell lines40, but never this effect was re-
ported in chondrocytes. Nevertheless, IL-6 effects were
weaker than those of IL-1b. Further, we did not ﬁnd a syn-
ergy between IL-1b and IL-6, suggesting that IL-6 plays an
anecdotal role in the antioxidant defenses impairment in
chondrocytes.
In conclusion, IL-1b, and to a lesser extend IL-6, dysregu-
lates enzymatic antioxidant defenses in chondrocyte. This
antioxidant deﬁciency is characterized by a rapid overproduc-
tionofMnSOD,adelayed increasedofGPXandadecreaseof
CAT activity. These changes could lead to a transient accu-
mulation of H2O2 in mitochondria, and consequently to mi-
tochondria damage. These changes contribute to explain
themitochondrial dysfunctionobserved inOAchondrocytes41.
These results also support the concept of the administration of
an antioxidant therapy to prevent chondrocyte aging, which is
an important feature in OA pathogenesis.
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